تجاوز إلى المحتوى الرئيسي
drug protocol number
DUT0012
drug sponsor
Sanofi-Aventis group
drug study
DUPIXENT® (Dupilumab)
drug trial site
Specialized Medical Center (Riyadh),Dr. Erfan & Bagedo General Hospital (Jeddah)
drug status
Completed
drug phase